Back to Peptides
Weight Loss
Liraglutide
Liraglutide is a GLP-1 receptor agonist with a daily dosing profile. As one of the earlier well-characterized incretin mimetics, it has an extensive human evidence base for appetite regulation, glucose control, and weight management, and remains a reference point in metabolic peptide research.
Weight LossMetabolicGLP-1SC
Research Benefits
Appetite suppression and satiety signaling documented
Glycemic control demonstrated across trials
Weight-management outcomes well established
Cardiovascular safety extensively studied
Axo's Research Digest
An AI-generated, plain-English overview of what the research explores for Liraglutide — and how mature that evidence is.